Anuh Pharma Ltd

NSE: ANUHPHR · BSE: 506260 · Pharmaceuticals & Biotechnology · 20 announcements

Share price: ₹85.51
Market cap: ₹857.0 Cr
Revenue (annual): ₹771.7 Cr
Net profit (annual): ₹41.05 Cr
P/E (TTM): 19.4×Sector 47.3×
Promoter holding: 71.80%+0.00% QoQ
FII holding: 0.01%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Financial Results 4 Other Announcement 3 Earnings Call 2 Annual General Meeting 2 Regulatory Approval 1 Promoter Reclassification 1 Management Change 1 Legal & Regulatory 1 Dividend 1 Debt & Borrowing 1 Board Meeting Date 1 Annual Report 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

30 Apr 2026 11:28 IST BSE

Debt & Borrowing

Anuh Pharma Debt & Borrowing

Anuh Pharma Ltd has confirmed it does not qualify as a 'Large Corporate' for FY 2026-27 as per SEBI criteria. While its equity is listed, it reports zero outstanding long-term borrowings and does not meet the required credit rating thresholds.

Execution: FY 2026-27

Read the filing ↗